INDEMNIFICATION AGREEMENTIndemnification Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into effective as of September 2, 2021 between Renovacor, Inc., a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), Matthew Killeen, PhD (the “Executive”), dated August 16, 2021.
FIRST AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO CONSULTING AGREEMENT (this “First Amendment”), is made and entered into effective as of September 2, 2021 (the “First Amendment Effective Date”) between Renovacor, Inc. (the “Company”) and Arthur M. Feldman (the “Consultant”). Capitalized terms that are used but not defined in this First Amendment shall have the meaning specified in the Agreement (as hereinafter defined).
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
THIS AGREEMENT (“Agreement”), effective this 12th day of August, 2019 (“Effective Date”), by and between Temple University – Of the Commonwealth System of Higher Education (hereinafter referred to as “University”) and Renovacor, Inc., a Delaware corporation, having a principal place of business at: 136 Knightsbridge Road, Wynnewood, PA 19096 (hereinafter referred to as “Sponsor”).
Amendment No. 2 to Sponsored Research AgreementSponsored Research Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 2 to Sponsored Research Agreement (“Amendment No. 2”) is entered into effective as of July 1, 2021 (“Amendment Date”) and amends that certain Sponsored Research Agreement effective August 12, 2019, as amended on August 27, 2019 (the Sponsored Research Agreement and first amendment collectively, the “Agreement”) between Temple University – Of The Commonwealth System of Higher Education (“University”) and Renovacor, Inc. (“Sponsor”). University and Sponsor are referred to herein collectively as “Parties” or individually as “Party”.
CONSULTING AGREEMENTConsulting Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This CONSULTING AGREEMENT (the “Agreement”) is entered into as of August 12, 2019 between Renovacor, Inc. (the “Company”) and Arthur M. Feldman (“Consultant”) (each of the foregoing individually a “Party” and collectively the “Parties”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 2, 2021 (the “Effective Date”), is made and entered into by and among Renovacor, Inc., a Delaware corporation (f/k/a Chardan Healthcare Acquisition 2 Corp.) (the “Company”), and each of the stockholders set forth on the signature pages hereto (each, a “Stockholder” collectively, the “Stockholders”).
Amendment No. 1 to Sponsored Research AgreementSponsored Research Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 (“Amendment No. 1”) is entered into effective August 27, 2019 (“Amendment Date”) and amends the Sponsored Research Agreement effective August 12, 2019 (the “Agreement”) between Temple University – Of The Commonwealth System of Higher Education (“University”) and Renovacor Inc., (“Sponsor”). University and Sponsor are referred to herein collectively as “Parties” or individually as “Party”.
LICENSE AGREEMENTLicense Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This License Agreement (“Agreement”) is made effective on the date of the last signature by and between Temple University - Of The Commonwealth System Of Higher Education (hereinafter referred to as “TEMPLE”), a corporation organized and existing under the laws of the Commonwealth of Pennsylvania, having a principal place of business at 1801 N. Broad St, Conwell Hall Rm 401, Philadelphia, Pennsylvania 19122 and Renovacor, Inc., (hereinafter referred to as “COMPANY”), a corporation organized and existing under the laws of the State of Delaware, having a principal place of business at 136 Knightsbridge Road, Wynnewood, PA 19096.
September 3, 2021 Dear Wendy,Retention Bonus Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This letter agreement documents the mutual understanding between Renovacor, Inc. (the “Company” or “we”) and you regarding a special retention bonus opportunity we are providing to you in connection with the closing of the transactions (the “Closing”) contemplated by the Agreement and Plan of Merger by and among the Company, CHAQ2 Merger Sub, Inc., and prior Renovacor, Inc. (which is now known as Renovacor Holdings, Inc.) dated March 22, 2021.
FORM OF EMPLOYMENT AGREEMENT1Employment Agreement • September 9th, 2021 • Renovacor, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This EMPLOYMENT AGREEMENT (this “Agreement”) is made, entered into by and between Renovacor, Inc., a Delaware corporation (the “Company”), and [EXECUTIVE NAME] (the “Executive”), dated [DATE].
